Search

everythinglearnresearchcommunity

for

Search:↓

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Genes and metabolites affect cashmere fiber thickness, which can improve cashmere quality.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Red light exposure can slow aging in mice by improving fat metabolism.

Nanozymes can restore hair growth by fixing peroxisomal function.

Nelfb is essential for dermal fat development and survival.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

MPZL3 protein helps control the size of oil glands and the growth of oil-producing cells in both mice and humans.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Mouse skin fibroblasts vary in function and adaptability based on their environment.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

G-1 promotes hair growth in female mice by activating specific signaling pathways.